Kumar SK, et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia 26: 149-157, 2011
Lonial S, et al. Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives. Leukemia 30: 526-535, 2016
His ED, et al. CS, a potential new therapeutic antibody target for the treatment of multiple myeloma. Clin Cancer Res 14: 2775-2784, 2008